Lipoprotein Changes May Be Minimized by Proper Composition of a Combined Oral Contraceptive
- 1 February 1981
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 35 (2), 172-179
- https://doi.org/10.1016/s0015-0282(16)45318-5
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- EFFECTS ON SEX HORMONE BINDING GLOBULIN OF DIFFERENT ORAL CONTRACEPTIVES CONTAINING NORETHISTERONE AND LYNESTRENOLBJOG: An International Journal of Obstetrics and Gynaecology, 1980
- Effects of contraceptive steroids on serum lipoproteins and cardiovascular disease scrutinized at workshop in BethesdaContraception, 1980
- Lipoprotein-cholesterol distributions in selected North American populations: the lipid research clinics program prevalence study.Circulation, 1980
- Plasma Lipids and High Density Lipoproteins during Oral Contraception with Different Combinations of Ethinyl Estradiol and LevonorgestrelHormone and Metabolic Research, 1979
- Hormonal contraceptives and plasma sex hormone binding globulinContraception, 1975
- The influence of hormonal contraceptives on sex hormone binding globulin (SHBG) capacityContraception, 1975
- A Simplified Method for the Quantitative Determination of Testosterone-Estradiol-Binding Globulin Activity in Human PlasmaJournal of Clinical Endocrinology & Metabolism, 1972
- EFFECTS OF COMBINED AND LOW-DOSE GESTAGEN ORAL CONTRACEPTIVES ON PLASMA LIPIDS; INCLUDING INDIVIDUAL PHOSPHOLIPIDSActa Endocrinologica, 1970
- ARE GONADAL HORMONES (ESTROGENS AND ANDROGENS) OF SIGNIFICANCE IN THE DEVELOPMENT OF ISCHEMIC HEART DISEASE?*Annals of the New York Academy of Sciences, 1968
- Quantitative Determination of Plasma Phospholipids in Pregnant and Non‐pregnant Women, with Special Reference to LysolecithinActa Medica Scandinavica, 1964